Fecal Occult Blood Test May Improve CRC Outcomes in Some
                    For men with left-sided tumors, those undergoing screening had lower N, M categories, higher survival                
            New AAP Guideline Available for Infantile Hemangioma Treatment
                    Early intervention and/or referral recommended for potentially problematic infantile hemangiomas                
            Risk of Arterial Thromboembolic Events Up Prior to Cancer Diagnosis
                    In seniors, risk of arterial thromboembolic events peaked in the 30 days immediately before diagnosis                
            Initiative Can Cut Gender Gap in Medical School Faculty Salaries
                    Overall mean salary gap by gender decreased from −2.6 to −1.9 percent after a decade                
            HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
                    HPV-16/18 confers strong future risk, particularly in women younger than 30 years                
            FDA Approves Drugs for Treatment of Two Rare Blood Diseases
                    Elzonris approved to treat BPDCN; Ultomiris approved for paroxysmal nocturnal hemoglobinuria                
            CDC: Weight, Waist Size, BMI Increased for Many U.S. Adults
                    1999-2000 to 2015-2016 saw increase in mean weight, waist circumference, BMI for many subgroups                
            FDA Warns Companies on Unsafe, Unapproved Stem Cell Treatments
                    Patients contracting deadly infections at clinics offering the unapproved treatments                
            Pembrolizumab Promising for Metastatic Head, Neck SCC
                    Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma                
            Sorafenib for Desmoid Tumors Ups Progression-Free Survival
                    Two-year progression-free survival rate 81 percent with sorafenib vs. 36 percent with placebo                
            
                
		
















